Skip to content

Ishinomaki Interstitial Lung Diseases Cohort Study

Ishinomaki Interstitial Lung Diseases Cohort Study - Ishinomaki ILD Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058592
Enrollment
300
Registered
2025-08-01
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial lung diseases

Interventions

None listed

Sponsors

Japanese Red Cross Ishinomaki Hospital
Lead Sponsor
IPPIN (Interstitial Pneumonia Protected by Ishinomaki Network)
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged 18 years or older at the time of enrollment. 2) Diagnosis of interstitial lung diseases confirmed by An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline 2022 and the corresponding guidelines for each diseases. 3) Ability to understand the study procedures and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who are not scheduled to undergo any of the tests in this study; 2) Patients who have undergone a lobectomy or greater by the time of enrollment; or 3) Patients who are deemed inappropriate by the principal investigator or subinvestigators for any other reason.

Design outcomes

Primary

MeasureTime frame
Prognosis

Secondary

MeasureTime frame
Clinical features, symptoms and physical findings, complications and comorbidities, blood and biochemical tests, chest imaging, respiratory function, and presence of acute exacerbations

Countries

Japan

Contacts

Public ContactSeiichi Kobayashi

Japanese Red Cross Ishinomaki Hospital Department of Respiratory Medicine

skoba-thk@umin.ac.jp0225-21-7220

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026